Signals mentioning Honasa Health
- Honasa calls off ₹135 crore acquisition of 58% stake in Fluence Pharma
- Honasa Consumer's called-off ₹135 crore Fluence Pharma acquisition resurfaces from August
- Honasa buys 58% of Fluence Pharma for Rs 135 cr, launches Honasa Health to enter VMS market
- Honasa buys 58% of Fluence Pharma, launches Honasa Health to enter nutraceuticals
- Honasa slips 3% after ₹135 cr Fluence Pharma deal to enter nutraceuticals
- Honasa buys 58% of Fluence Pharma for Rs 135 cr, launches Honasa Health for nutraceuticals
- Honasa buys 58% of Fluence Pharma at ₹135 cr EV, enters ₹16,000-cr nutraceuticals via Honasa Health
- Honasa Buys 58% of Fluence Pharma for Rs 135 Cr, Launches Honasa Health for Nutraceuticals
- Honasa Consumer acquires 58% of Fluence Pharma at Rs 135 cr EV, launches Honasa Health subsidiary
- Honasa Buys 58% Of Fluence Pharma, Pushes Mamaearth Into Beauty-From-Within
- Honasa buys 58% of Fluence Pharma at ₹135 cr EV, enters ₹16,000 cr nutraceuticals market
- Honasa Consumer to acquire 58% of Fluence Pharma at Rs 135 cr EV, enters Rs 16,000 cr supplements market
- Honasa buys 58% of Fluence Pharma for Rs 135 Cr, launches Honasa Health for nutraceuticals push
- Honasa buys 58% of Fluence Pharma for Rs 135 Cr, launches Honasa Health for D2C wellness play